Marsden, J.

patient interferon trial melanoma group survival observation stage treatment adjuvant study metastasis-free survival pegylated interferon group observation group eortc disease recurrence-free survival analysis event hospital therapy cancer oncol number month signi adjuvant therapy phase recurrence-free randomised e ffect ifn-a ficant oncology table nodal university tumour involvement resected nodal involvement value metastasis-free duration eggermont effect stage iii melanoma death hazard ratio centre low-dose vaccine signi ficant prognostic randomisation toxicity analyses lymph randomized result recurrence impact randomised trial lymph nodes nodal disease signi ficant effect p value suciu stage ii metastase oncology group signi ficant impact grade univariate randomised trials follow-up 5 years univariate analysis